Physician profile
Charles J Rodman
NPI 1316002785
$4,997.99
in general payments reported to CMS, 2019-2025
18 companies · $1,441 in 2025
The $1,441 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $173 · 2021: $607 · 2022: $670 · 2023: $734 · 2024: $1,094 · 2025: $1,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,268.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,353.44 | 2020-2025 | Varithena Administration Pack, General - Vascular Intervention |
| Tactile Systems Technology INC | $1,314.28 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Urgo Medical North America, LLC | $1,094.24 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Medtronic, INC. | $336.58 | 2021-2025 | Venaseal |
| Bard Peripheral Vascular, INC. | $249.12 | 2021-2025 | Venclose Maven Catheter, Fluency Endovascular Stent Graft |
| Medtronic Vascular, INC. | $174.79 | 2019-2020 | |
| Smith+Nephew, INC. | $127.50 | 2021 | |
| Venclose INC. | $67.12 | 2019 | |
| Biocompatibles, INC. | $60.53 | 2019 | |
| Organogenesis INC. | $48.24 | 2022 | |
| Mimedx Group, INC. | $31.92 | 2024-2025 | |
| Reprise Biomedical, INC. | $27.29 | 2025 | Miro3d, Miro 3d |
| Abbvie INC. | $26.91 | 2024 | |
| Kci USA, INC. | $24.42 | 2021 | |
| Hartmann USA, INC. | $22.42 | 2025 | Twopress 2 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $17.31 | 2023 | Cutimed Sorbact |
| Kerecis Limited | $13.14 | 2021 | |
| Cashflow Solutions, LLC | $8.74 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Rodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.